JNJ COVID-19 vaccine and risks from delta variant: experts are already taking booster shots

Jun. 26, 2021 9:06 PM ETJohnson & Johnson (JNJ)JNJ, PFE, MRNA, BNTXBy: Dulan Lokuwithana, SA News Editor162 Comments

Toyota Auto Plant In West Virginia Partners With State To Hold Vaccination Event For Employees
Stephen Zenner/Getty Images News

  • Given the increasing prevalence of the highly transmissible delta variant, some infectious disease experts who received the single-shot COVID-19 vaccine from Johnson & Johnson (NYSE:JNJ) have obtained messenger-RNA-based vaccines as boosters, Reuters reports.
  • While JNJ said it

Recommended For You

Comments (162)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.